×

SKIN
CANCER
CONNECT

August 2022

CASTLE BIOSCIENCES' PUBLICATIONS FEATURED IN SKIN'S 5-YEAR ANNIVERSARY EDITION

SKIN presented their Five-Year Anniversary Special Edition Issue of SKIN, The Journal of Cutaneous Medicine® . This special issue included the top 20 most read articles in the journal’s five-year history that had the largest impact on clinical care.

 

One of these articles featured the analysis demonstrating the clinical value of DecisionDx-Melanoma in risk of recurrence thin tumors. A second article featured the initial development and validation study of DiffDx-Melanoma for use in patients with an ambiguous or difficult-to-diagnose suspicious pigmented skin lesion.

Stocksy_txpe2a7a963g7n200_OriginalDelivery_2981128-scaled
Case-Study-1-5
CASE STUDY OF THE MONTH

Asymmetrical Pigmented Lesion​ with High Clinical Suspicion for Melanoma​

A 27-year-old female patient was seen by a primary care physician who recommended follow-up with a dermatologist for assessment of a concerning melanocytic lesion.

 

AdobeStock_259660705-scaled
RESEARCH & DEVELOPMENT

Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test

A new publication focused on DecisionDx-Melanoma was recently accepted in the Journal of the American Academy of Dermatology.

NOT REGISTERED?
NO PROBLEM!

Sign up for access to our monthly newsletter online
and directly in your inbox each month.

Scroll to Top